Protalix BioTherapeutics (PLX) Inventory (2010 - 2026)
Protalix BioTherapeutics' quarterly Inventory came in at $30.5 million in Q1 2026, up 56.23% year-on-year from $19.5 million in Q1 2025, and up 18.44% quarter-over-quarter from $25.7 million in Q4 2025.
Protalix BioTherapeutics has reported Inventory for 17 years, with the latest figure at $30.5 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 56.23% year-over-year to $30.5 million; the trailing twelve-month figure through Mar 2026 stood at $30.5 million (up 56.23% YoY), and the FY2025 full-year result was $25.7 million, up 21.12% from the prior year.
- Inventory for Q1 2026 stood at $30.5 million, up from $25.7 million in the prior quarter.
- The five-year high for Inventory was $30.5 million in Q1 2026, with the low at $14.6 million in Q3 2022.
- Average Inventory over 5 years is $20.3 million, with a median of $20.3 million recorded in 2023.
- Year-over-year, Inventory slipped 20.31% in 2024 and jumped 56.23% in 2026.
- Tracing PLX's Inventory over 5 years: stood at $16.8 million in 2022, then grew by 13.34% to $19.0 million in 2023, then grew by 11.54% to $21.2 million in 2024, then grew by 21.12% to $25.7 million in 2025, then advanced by 18.44% to $30.5 million in 2026.
- The last three Inventory figures came in at $30.5 million (Q1 2026), $25.7 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 30.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.47 Mn |
| Dec 31, 2025 | 25.73 Mn |
| Sep 30, 2025 | 21.26 Mn |
| Jun 30, 2025 | 21.13 Mn |
| Mar 31, 2025 | 19.51 Mn |
| Dec 31, 2024 | 21.24 Mn |
| Sep 30, 2024 | 17.20 Mn |
| Jun 30, 2024 | 20.72 Mn |
| Mar 31, 2024 | 22.35 Mn |
| Dec 31, 2023 | 19.05 Mn |
| Sep 30, 2023 | 21.58 Mn |
| Jun 30, 2023 | 19.64 Mn |
| Mar 31, 2023 | 20.30 Mn |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 14.56 Mn |
| Jun 30, 2022 | 16.51 Mn |
| Mar 31, 2022 | 16.59 Mn |
| Dec 31, 2021 | 17.95 Mn |
| Sep 30, 2021 | 14.73 Mn |
| Jun 30, 2021 | 13.64 Mn |
| Mar 31, 2021 | 13.92 Mn |
| Dec 31, 2020 | 13.08 Mn |
| Sep 30, 2020 | 13.28 Mn |
| Jun 30, 2020 | 11.07 Mn |
| Mar 31, 2020 | 9.49 Mn |
| Dec 31, 2019 | 8.16 Mn |
| Sep 30, 2019 | 7.53 Mn |
| Jun 30, 2019 | 7.00 Mn |
| Mar 31, 2019 | 6.71 Mn |
| Dec 31, 2018 | 8.57 Mn |
| Sep 30, 2018 | 7.96 Mn |
| Jun 30, 2018 | 6.98 Mn |
| Mar 31, 2018 | 7.02 Mn |
| Dec 31, 2017 | 7.83 Mn |
| Sep 30, 2017 | 7.48 Mn |
| Jun 30, 2017 | 7.06 Mn |
| Mar 31, 2017 | 7.10 Mn |
| Dec 31, 2016 | 5.25 Mn |
| Sep 30, 2016 | 4.86 Mn |
| Jun 30, 2016 | 6.07 Mn |
| Mar 31, 2016 | 5.74 Mn |
| Dec 31, 2015 | 5.77 Mn |
| Dec 31, 2014 | 3.45 Mn |
| Mar 31, 2014 | 6.53 Mn |
| Dec 31, 2013 | 7.96 Mn |
| Sep 30, 2013 | 7.58 Mn |
| Jun 30, 2013 | 7.19 Mn |
| Mar 31, 2013 | 5.77 Mn |
| Dec 31, 2012 | 4.04 Mn |
| Sep 30, 2012 | 2.06 Mn |
| Jun 30, 2012 | 1.03 Mn |
| Mar 31, 2012 | 263,000.00 |
| Dec 31, 2011 | 279,000.00 |
| Sep 30, 2011 | 427,000.00 |
| Jun 30, 2011 | 537,000.00 |
| Dec 31, 2010 | 1.19 Mn |